UnitedHealthcare Airway Clearance Devices Coverage Update

Coverage Criteria for Airway Clearance Devices

State-specific coverage for HFCWO (E0483)

Covered when ANY one of the following is met:

Covered indications: Diagnosis of cystic fibrosis

Covered indications: Diagnosis of bronchiectasis characterized by either (a) daily productive cough for at least 6 continuous months OR (b) more than 2 exacerbations per year requiring antibiotic therapy; and confirmed by high-resolution, spiral, or standard CT scanSee bronchiectasis threshold: daily productive cough ≥6 months OR >2 exacerbations/year

Covered indications: Neuromuscular disorder

Coverage pathway: well-documented failure of standard treatments

Failure item: Chest physical therapy and flutter device at least twice daily (when age appropriate)
Failure item: A pattern of hospitalizations at least annually or more
Failure item: Significantly deteriorating clinical condition
Failure item: Be under the care of a pulmonologist
Failure item: Copies of two pulmonary test results that indicate the beneficiary's condition improved with the use of the vest

Not medically necessary / unproven devices

The following are considered unproven and not medically necessary for the indicated uses:

Not medically necessary: Combination continuous positive expiratory pressure (CPEP), continuous high frequency oscillation (CHFO), and nebulized medication therapy devices for oscillation and lung expansion (OLE)

Considered unproven due to insufficient quality or consistency of evidence

Not medically necessary: Intrapulmonary percussive ventilation (IPV) devices for home use

Insufficient quality evidence or consistency of findings to support long-term home use

Evidence summaries and guideline context

Document summarizes clinical evidence and guideline positions; no explicit stepwise medical necessity criteria are provided in this portion.

OLE evidence: Huynh et al. (2019) prospective multicenter non-randomized study (n=419) reported reduced postoperative pulmonary complications (PPCs) (22.9% → 15.8%), reduced ventilator time and shorter hospital length of stay with OLE treatment, but authors call for well-designed RCTs to confirm safety and efficacy.

IPV evidence—insufficient: Systematic reviews and small RCTs provide weak or inconsistent evidence for IPV effectiveness (e.g., limited/small studies, heterogeneity, mixed physiologic and clinical results); routine or long-term home use is not supported by sufficiently strong evidence.

Guideline positions: Professional guideline statements vary: AAN states insufficient data to support or refute HFCWC for airway clearance in ALS; ACCP (CHEST) found insufficient evidence that any airway clearance technique is consistently superior in bronchiectasis; ATS recommends assisted cough techniques and mechanical insufflation-exsufflation for DMD patients with low peak cough flow or low maximal expiratory pressures.

Use of combination CPEP/CHFO/OLE devices and home use IPV are excluded as not medically necessary. This policy designates combination continuous positive expiratory pressure, continuous high frequency oscillation, and nebulized medication therapy devices for oscillation and lung expansion (OLE) as unproven and not medically necessary, and similarly considers intrapulmonary percussive ventilation devices intended for home use to be unproven and not medically necessary.

The routine use of intrapulmonary percussive ventilation (IPV) as an airway clearance technique for chronic obstructive airway diseases is not recommended due to insufficient evidence. Systematic reviews and clinical studies report heterogeneous and generally weak results, with no clear advantage of IPV over other airway clearance techniques in stable patients; guideline and review conclusions recommend against routine IPV use in this population.

Combination oscillation and lung expansion (OLE) devices—defined as combined CPEP, CHFO, and nebulized medication therapy—are considered unproven and not medically necessary for the indicated uses. Likewise, IPV devices for home use are judged unproven and not medically necessary given the current lack of sufficient quality evidence and consistency of findings to support long-term home therapy.

Long-term home use of intrapulmonary percussive ventilation (IPV) lacks sufficient high-quality evidence or consistent findings to support coverage. Systematic reviews and small studies report weak or inconsistent benefits for ICU length of stay, gas exchange, and other clinical outcomes, and authors note heterogeneity, small sample sizes, and methodological limitations that preclude firm conclusions about therapeutic value in the home setting.

Billing and Diagnosis Codes

Applicable HCPCS/CPT codes (device and supplies)HCPCS

A7021	Supplies and accessories for lung expansion airway clearance, continuous high frequency oscillation, and nebulization device (e.g., handset, nebulizer kit, biofilter).
A7025	High frequency chest wall oscillation system vest, replacement for use with patient- owned equipment, each.
A7026	High frequency chest wall oscillation system hose, replacement for use with patient- owned equipment, each.
E0469	Lung expansion airway clearance, continuous high frequency oscillation, and nebulization device.
E0481	Intrapulmonary percussive ventilation system and related accessories.
E0483	High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, each.

Applicable ICD-10 codes (selected examples from list)ICD-10

E84.0	Cystic fibrosis with pulmonary manifestations.
E84.9	Cystic fibrosis, unspecified.
J47.9	Bronchiectasis, uncomplicated.
J47.1	Bronchiectasis with (acute) exacerbation.
G12.21	Amyotrophic lateral sclerosis.
G12.1	Other inherited spinal muscular atrophy.
G71.00	Muscular dystrophy, unspecified.
Z99.11	Dependence on respirator [ventilator] status.

Applicable ICD-10 diagnosis code edits (policy history)ICD-10

G35.A	ICD-10 diagnosis code added (as listed in policy history)
G35.B0	ICD-10 diagnosis code added (as listed in policy history)
G35.B1	ICD-10 diagnosis code added (as listed in policy history)
G35.B2	ICD-10 diagnosis code added (as listed in policy history)
G35.C0	ICD-10 diagnosis code added (as listed in policy history)
G35.C1	ICD-10 diagnosis code added (as listed in policy history)
G35.C2	ICD-10 diagnosis code added (as listed in policy history)
G35.D	ICD-10 diagnosis code added (as listed in policy history)
G71.036	ICD-10 diagnosis code added (as listed in policy history)
G35	ICD-10 diagnosis code removed (as listed in policy history)

Bronchiectasis criteria — symptom duration and exacerbation frequency

Bronchiectasis symptom thresholdDaily productive cough for at least 6 continuous months

Bronchiectasis exacerbation threshold>2 exacerbations per year requiring antibiotic therapy

Imaging confirmationBronchiectasis must be confirmed by high-resolution, spiral, or standard CT scan

Provider Requirements, Prior Auth, and Documentation

Prior Authorization

Prior Authorization Required

High-frequency chest wall oscillation devices (HCPCS E0483) require prior authorization. Coverage is state-specific; provide the state-required clinical criteria and supporting documentation with the request.

Affected code: E0483

Denial Risk

Denial Risk for Missing Criteria or Documentation

Requests for E0483 may be denied if the beneficiary does not meet the applicable state-specific criteria, or if required documentation is missing.

Denial triggers: missing diagnosis, no documentation of failed conservative therapy, absence of required test results

Background and Scope

Airway clearance is commonly impaired in conditions such as cystic fibrosis, bronchiectasis, chronic obstructive pulmonary disease, and neuromuscular or metabolic disorders because of increased secretion volume or viscosity and/or an ineffective cough. These impairments can lead to retained secretions that require assisted clearance. Mechanical modalities described in this policy include high-frequency chest wall oscillation (HFCWO) vests, which rapidly inflate and deflate to mobilize secretions, and intrapulmonary percussive ventilation (IPV), which delivers rapid mini-bursts of gas to mobilize endobronchial secretions.

Device Definitions

High-frequency chest wall oscillation (HFCWO)

DefinitionMechanical chest physiotherapy using an inflatable vest connected to an air-pulse generator that rapidly inflates and deflates (up to ~20 Hz) to mobilize secretions

MechanismVest compression/release creates vibratory forces thought to lower mucus viscosity and improve mucociliary clearance

Use caseUsed when coughing alone cannot adequately clear secretions to allow independent airway clearance management

Intrapulmonary percussive ventilation (IPV)

DefinitionMechanized chest physiotherapy delivering mini bursts (>200 per minute) of respiratory gases via a mouthpiece to mobilize endobronchial secretions

Adjustable parameters

OpenPayer

Airway Clearance Devices (for Louisiana Only)

Coverage Criteria for Airway Clearance Devices

Billing and Diagnosis Codes

Provider Requirements, Prior Auth, and Documentation

Background and Scope

Device Definitions